skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection

Journal Article · · Cell

HIV-1-neutralizing antibodies develop in most HIV-1-infected individuals, although highly effective antibodies are generally observed only after years of chronic infection. Here in this paper, we characterize the rate of maturation and extent of diversity for the lineage that produced the broadly neutralizing antibody VRC01 through longitudinal sampling of peripheral B cell transcripts over 15 years and co-crystal structures of lineage members. Next-generation sequencing identified VRC01-lineage transcripts, which encompassed diverse antibodies organized into distinct phylogenetic clades. Prevalent clades maintained characteristic features of antigen recognition, though each evolved binding loops and disulfides that formed distinct recognition surfaces. Over the course of the study period, VRC01-lineage clades showed continuous evolution, with rates of ~2 substitutions per 100 nucleotides per year, comparable to that of HIV-1 evolution. This high rate of antibody evolution provides a mechanism by which antibody lineages can achieve extraordinary diversity and, over years of chronic infection, develop effective HIV-1 neutralization.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES); National Institutes of Health (NIH)
Grant/Contract Number:
W-31-109-Eng-38; P01-AI104722
OSTI ID:
1392136
Alternate ID(s):
OSTI ID: 1221428
Journal Information:
Cell, Journal Name: Cell Vol. 161 Journal Issue: 3; ISSN 0092-8674
Publisher:
ElsevierCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 165 works
Citation information provided by
Web of Science

Cited By (43)

Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial journal November 2017
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting journal January 2017
Progress toward active or passive HIV-1 vaccination journal December 2016
Gene-Specific Substitution Profiles Describe the Types and Frequencies of Amino Acid Changes during Antibody Somatic Hypermutation journal May 2017
Computational Strategies for Dissecting the High-Dimensional Complexity of Adaptive Immune Repertoires journal February 2018
Development of a Potent and Protective Germline-Like Antibody Lineage Against Zika Virus in a Convalescent Human journal October 2019
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting text January 2017
Broadly Neutralizing Antibodies for HIV Eradication journal February 2016
Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice journal February 2016
Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain journal November 2016
Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation journal October 2018
Improvement of antibody functionality by structure-guided paratope engraftment journal February 2019
Large-scale network analysis reveals the sequence space architecture of antibody repertoires journal March 2019
High-throughput sequencing of IgG B-cell receptors reveals frequent usage of the rearranged IGHV4–28/IGHJ4 gene in primary immune thrombocytopenia journal June 2019
Longitudinal analysis of the antibody repertoire of a Zika virus-infected patient revealed dynamic changes in antibody response journal January 2020
Extensive dissemination and intraclonal maturation of HIV Env vaccine-induced B cell responses journal November 2019
Yvis: antibody high-density alignment visualization and analysis platform with an integrated database journal May 2019
Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults: VRC01 HIV-1 mAb in healthy adults journal September 2015
B-cell responses to HIV infection journal January 2017
Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen journal June 2015
Targeted selection of HIV-specific antibody mutations by engineering B cell maturation journal December 2019
The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen journal July 2018
Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection journal June 2015
Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies journal December 2018
Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop journal January 2016
Spatiotemporal hierarchy in antibody recognition against transmitted HIV-1 envelope glycoprotein during natural infection journal February 2016
HIV evolution and diversity in ART-treated patients journal January 2018
The expanding array of HIV broadly neutralizing antibodies journal October 2018
Systemic translocation of Staphylococcus drives autoantibody production in HIV disease journal February 2019
Integrating linear optimization with structural modeling to increase HIV neutralization breadth journal February 2018
The breadth of HIV-1 neutralizing antibodies depends on the conservation of key sites in their epitopes journal June 2019
A simplified workflow for monoclonal antibody sequencing journal June 2019
Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design journal August 2016
HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies journal November 2018
High-Throughput Sequencing-Based Immune Repertoire Study during Infectious Disease journal August 2016
Analyzing Immunoglobulin Repertoires journal March 2018
Benchmarking Tree and Ancestral Sequence Inference for B Cell Receptor Sequences journal October 2018
Antibody Cross-Reactivity in Antivenom Research journal September 2018
Advances in HIV-1 Vaccine Development journal April 2018
Exploiting B Cell Receptor Analyses to Inform on HIV-1 Vaccination Strategies journal January 2020
A Database of Human Immune Receptor Alleles Recovered from Population Sequencing Data journal January 2017
Observed Antibody Space: A Resource for Data Mining Next-Generation Sequencing of Antibody Repertoires journal September 2018
Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core journal November 2018